Stroke Care in 2026: New Guidelines and the Skills Behind a Faster Response
When a stroke occurs, every decision is made against the clock. Recognizing the symptoms, determining the most appropriate destination, communicating findings, completing imaging, and beginning treatment must happen quickly—and in coordination.
The 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke, released by the American Heart Association and American Stroke Association in January 2026, reflects how significantly acute stroke care has advanced since the previous guideline and its 2019 update.
The new recommendations expand treatment possibilities for certain patients, refine prehospital decision-making, and introduce the first detailed guidance for pediatric acute ischemic stroke. Together, they reinforce a central lesson for every member of the stroke response team: better outcomes depend not only on which treatments are available, but also on how quickly and effectively the system delivers them.
Faster Care Begins Before the Patient Reaches the Hospital
One of the guideline’s clearest themes is that stroke care begins with the first emergency call—not at the hospital door.
The updated guidance supports the use of mobile stroke units when they are available. These specialized ambulances can include CT imaging capabilities and stroke-trained clinicians, allowing eligible patients to be evaluated and treated sooner.
The guideline also takes a more nuanced approach to EMS destination decisions. Previous guidance generally prioritized transport to the nearest hospital capable of providing thrombolytic medication. The 2026 update recognizes that some patients with a suspected large-vessel occlusion may benefit from direct transport to the closest thrombectomy-capable stroke center.
That decision still depends on the local stroke system, geography, transport times, and the speed of interhospital transfers. There is no universal destination rule. Instead, EMS agencies and hospitals need coordinated protocols that move each patient toward the appropriate care without unnecessary delays.
For patients who do require transfer, reducing “door-in-door-out” time at the first hospital is another important priority.
More Options for Clot-Busting Treatment
Intravenous thrombolysis remains a foundation of acute ischemic stroke treatment. Under the new guideline, either alteplase or tenecteplase may be used for eligible patients within the standard 4.5-hour treatment window.
Tenecteplase is administered as a single IV dose, which may simplify and accelerate treatment compared with alteplase’s longer infusion.
The guideline also emphasizes that patients with disabling neurological deficits should receive rapid thrombolytic treatment when eligible, regardless of whether their National Institutes of Health Stroke Scale score appears low. A seemingly “minor” numerical score can still represent a deficit with a major effect on the patient’s ability to communicate, work, walk, or live independently.
For patients with non-disabling deficits, however, trials have not demonstrated the same benefit from thrombolysis. The guideline recommends dual antiplatelet therapy for this population. The distinction is not simply between a “mild” and “severe” stroke; clinicians must evaluate whether the specific deficit is disabling for that patient.
Advanced imaging may also identify selected patients who can benefit from thrombolysis beyond the traditional window, including some people who awaken with symptoms or whose time of onset is unknown. These are carefully selected cases—not a general extension of the treatment window.
Thrombectomy Eligibility Has Expanded
Endovascular thrombectomy, or EVT, removes a clot directly from a blocked artery. It is an established treatment for eligible patients with large-vessel occlusion, but the 2026 guideline expands the populations that may be considered.
Selected patients may now qualify even when imaging shows a larger area of established injury, sometimes referred to as a large ischemic core. The guideline also strengthens the role of EVT for certain posterior-circulation strokes, including basilar artery occlusion.
For patients with basilar artery occlusion, an NIHSS score of 10 or higher, and presentation within 24 hours, the guideline provides a strong recommendation for EVT. Some patients with mild or moderate disability that existed before the stroke may also benefit when treated within six hours.
When a patient qualifies for both a clot-busting medication and thrombectomy, treatment should proceed rapidly and sequentially. Teams should not delay EVT to wait and see whether symptoms improve after medication.
At the same time, the guideline does not recommend routine thrombectomy for smaller blockages in medium or small cerebral arteries outside appropriate research settings.
Imaging and Supportive Care Remain Critical
Hospitals should aim to complete initial brain imaging within 25 minutes of arrival. Imaging must quickly distinguish ischemic stroke from hemorrhage and help determine whether the patient may qualify for thrombolysis, thrombectomy, or another treatment pathway.
The guideline also cautions against assuming that more aggressive supportive treatment always produces better results. Intensive glucose control to a range of 80–130 mg/dL is not recommended because it increases the risk of severe hypoglycemia without improving clinical outcomes.
Similarly, intensive lowering of systolic blood pressure below 140 mm Hg after thrombectomy is not recommended and may cause harm—even after blood flow has been fully restored.
The First Detailed Guidance for Pediatric Stroke
For the first time, the acute ischemic stroke guideline includes detailed recommendations for infants, children, and adolescents.
Stroke is less common in children, and its symptoms can be mistaken for migraine, seizure, traumatic injury, or other conditions. The guideline advises rapid MRI and magnetic resonance angiography when these technologies can be accessed promptly, with CT considered when timely MRI is unavailable.
Alteplase may be considered within 4.5 hours for children from 28 days through 18 years of age who have disabling deficits. Thrombectomy may also benefit carefully selected children with large-vessel occlusion when performed by experienced pediatric and neurointerventional teams.
The evidence base for pediatric treatment remains more limited than it is for adults, but these recommendations provide an important foundation for more consistent recognition and care.
Course Highlight: Advanced Stroke Life Support
New evidence can only improve outcomes when healthcare professionals are prepared to recognize a stroke, communicate effectively, and act within an organized system.
The American Heart Association’s Advanced Stroke Life Support® course, developed in partnership with the University of Miami’s Gordon Center, prepares healthcare professionals to identify, evaluate, and manage patients experiencing stroke.
ASLS is designed for professionals involved in acute stroke care, including:
Nurses and nursing students
Advanced practice registered nurses
Physicians and physician assistants
Residents, fellows, and medical students
Paramedics and emergency medical personnel
Respiratory therapists
Stroke coordinators
Learners can choose a prehospital track, an in-hospital track, or a combined track covering both environments.
The course uses a blended format. Students first complete an adaptive, self-directed online component and receive an online completion certificate. They then attend an in-person skills session through an affiliated AHA Training Center.
During the hands-on portion, learners are evaluated across three essential areas: performing neurological examinations, diagnosing stroke presentations, and managing patients with stroke. Those who successfully complete all course requirements receive an AHA ASLS Provider eCard. Continuing education credit may be available depending on the selected track and the learner’s profession.
As an AHA ASLS Training Center, ACLS Academy regularly provides this advanced training with instructors who understand the realities of clinical care. It is an extension of the approach behind every ACLS Academy course: For Providers, by Providers.
Turning Evidence Into a Coordinated Response
The 2026 guideline expands what may be possible for patients once considered outside traditional treatment criteria. But it also makes clear that advanced medications and procedures cannot compensate for delays in recognition, assessment, communication, imaging, or transfer.
Effective stroke care depends on people who know what to look for, how to communicate what they find, and what needs to happen next.
ASLS gives healthcare professionals an opportunity to practice those responsibilities before the next stroke emergency begins. Explore upcoming Advanced Stroke Life Support training with ACLS Academy and build the skills that support a faster, more coordinated response.
Explore More
Stroke readiness extends beyond a single guideline update. Explore more ACLS Academy resources on stroke recognition, emergency response, and the training that helps healthcare professionals act with confidence.
Could You Spot the Signs of A Stroke?
Stroke Awareness Month: Beyond Genetics and Age, What Is Increasing Your Risk
Another ACLS Academy Triumph: Achieving AHA Training Center Certification for ASLS
Whether you're preparing for your first nursing position or advancing into a specialty role, ACLS Academy offers American Heart Association and specialty certification courses taught by practicing healthcare professionals. Training includes BLS, ACLS, PALS, PEARS, ACLS EP, ASLS, NRP, TNCC, ENPC, Intermediate Fetal Heart Monitoring, Instructor Courses, and Heartsaver CPR/AED & First Aid. With convenient training locations in Quincy, Bridgewater, and Newton Centre, Massachusetts, plus onsite group training throughout New England, ACLS Academy helps healthcare providers gain the knowledge and confidence to respond when every second counts.